Kalderos provides a SaaS based drug discount management solution, which identifies, checks, and resolves non-compliance.
Kalderos has raised $26.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.
Kalderos's investors include Alumni Ventures, Bain Capital Ventures, Mercato Partners.
Kalderos is headquartered in Chicago, United States.
Kalderos provides a SaaS based drug discount management solution, which identifies, checks, and resolves non-compliance.
Kalderos is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kalderos — Funding & Investors." VCBacked, January 3, 2025, https://www.vcbacked.co/company/kalderos. Accessed July 20, 2026.
VCBacked. (2025). Kalderos — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/kalderos
{{cite web |title=Kalderos — Funding & Investors |url=https://www.vcbacked.co/company/kalderos |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated